CSE PREV
LAST 0.020
CHANGE 0.000
OTC PRVCF
FSE 18H
CSE: PREV
LAST: 0.020
CHANGE: 0.000
OTC: PRVCF
FSE: 18H

Stephen Van Deventer

Chairman & Chief Executive Officer 

Mr. Van Deventer is an experienced business person and corporate director. Specialising in international corporate relations and business development over the last twenty-five years, Mr. Van Deventer has focused on launching small to medium-sized companies into the public markets in Canada, the United States and Europe. He has also owned and operated private businesses.

Mak JawadekarPh.D.

President & Chief Science Officer

Dr. Mak Jawadekar worked at Pfizer Inc. in Groton-New London, Connecticut, for 28 consecutive years. His most recent position was as a Director of Portfolio Management at Pfizer Inc. He was responsible for Drug Delivery Technology Assessment function involving external ‘Drug Delivery’ technologies. He has extensive experience in creating and cultivating external partnerships and alliances for drug delivery technologies. He began his professional career at Pfizer Central Research in early 1982, after having completed his Ph.D. in Pharmaceutics at the University of Minnesota.

Shabira RajanMBA, CPA, CGA

Chief Financial Officer & Controller

Ms. Rajan is a senior financial executive with over 20 years of experience, leading the financial discipline for successful businesses in both private and public sectors. She has a track record of providing leadership for strategic value creation and continuous improvement, as well as, providing effective direction to organisations on issues relating to corporate governance, financial oversight and risk management. One of her leadership roles was that of Director of Finance at Canada Line Rapid Transit Inc., which planned and constructed a $2 billion rapid transit system in metro-Vancouver, on time and within budget.

Harry ParekhPh.D., MRPharmS

Chief Research Officer

Based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), Dr. Parekh also holds adjunct positions at the National University of Singapore, and Manipal University, India. Dr. Parekh heads the Drug/Gene Delivery Group at PACE-UQ with his team developing highly innovative and translational medicine delivery systems in-conjunction with physicians whose expertise span cancer, obesity-&-diabetes, macular disease, infectious disease and traditional (Chinese) medicine.

Alicia Rebman

Marketing Director

Ms. Rebman is a Marketing professional with a background in Publishing Technologies, Communications, and Graphic Design; specialty in branding/communications for social enterprise and NGO start-ups. Ms. Rebman ran a successful design services company for six years and afterwards headed the marketing department for the Global office of Hartley & Marks Group, an international design & publishing company.

Sydney Cole

Executive Assistant & Office Manager

Ms. Cole has held Administration Support and trainer roles within the Hospitality Industry for seven years. Ms. Cole has also worked for a Venture Capital company for five years as an executive assistant and office manager. From bookkeeping to event coordination Ms. Cole’s organisation and fortitude keep operations running smoothly.

Nicole Goncalves-Krysinski

Foreign Legal Advisor

Nicole Goncalves-Krysinski, Esq., is an attorney and a partner in her law firm in New York City, New York. She has a J.D. from St. John’s University and B.A. from U.C.L.A. Nicole practices in both state and federal courts handling a broad range of cases including complex bankruptcy matters, matrimonial, and criminal defence litigation. Her areas of practice also include contract negotiations, business and transactional law and corporate advisement.

Sign up for the latest news and updates